当前位置: 首页 > 期刊 > 《医药产业资讯》 > 202020
编号:13829195
姜黄素药理作用及机制研究进展(6)
http://www.100md.com 2020年7月15日 《中国医药导报》 202020
     [37] Xiao J,Sheng X,Zhang X,et al. Curcumin protects against myocardial infarction-induced cardiac fibrosis via SIRT1 activation in vivo and in vitro [J]. Drug Des Devel Ther,2016,10:1267-1277.

    [38] Huang R,Liu Y,Xiong Y,et al. Curcumin protects against liver fibrosis by attenuatinginfiltration of Gr1hi monocytes through inhibition of monocyte chemoattractant protein-1 [J]. Discov Med,2016,21(118):447-457.

    [39] Chauhan PS,Dash D,Singh R. Intranasal Curcumin Inhibits Pulmonary Fibrosis by Modulating Matrix Metalloproteinase-9(MMP-9)in Ovalbumin-Induced Chronic Asthma [J]. Inflammation,2017,40(1):248-258.

    [40] Liu Y,Liu Y,Huang X,et al. Protective effects and mechanism of curcumin on myocardial injury induced by coronary microembolization [J]. J Cell Biochem,2019, 120(4):5695-5703.

    [41] Liu H,Wang C,Qiao Z,et al. Protective effect of curcumin against myocardium injury in ischemia reperfusion rats [J]. Pharm Biol,2017,55(1):1144-1148.

    [42] Li X,Cao T,Ma S,et al. Curcumin ameliorates cardiac dysfunction induced by mechanical trauma [J]. Eur J Pharmacol,2017,814:73-80.

    (收稿日期:2020-01-09), 百拇医药(宋莉平 王宇)
上一页1 2 3 4 5 6